Sinopharm Group (HKG:1099) reported a net profit attributable to the parent of 3.70 billion yuan for the first six months ended June 30, a 9.76% decline compared with the 4.10 billion yuan profit reported in the year-ago period, according to the company's interim report filed with the Hong Kong bourse Wednesday.

Earnings per share were 1.19 yuan per share, down from 1.32 yuan per share a year earlier.

Revenue of the pharmaceutical company fell to 294.73 billion yuan from 300.95 billion yuan in the prior-year period

Price (HKD): $17.98, Change: $+0.74, Percent Change: +4.29%